News and resources | Resources
Video 1 November 2012

26th IFPMA assembly – IFPMA president’s inaugural address

By IFPMA
Share

Geneva, October 31, 2012

Dr. John C. Lechleiter, Chairman, President and CEO, Eli Lilly and Company

 

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.

Learn more

Media Contact

Elliot Dunster

Related news and resources

Statement 5 Jun 2023

G20 3rd Health Working Group Meeting: Health Emergencies Prevention, Preparedness, and Response (HEPPR)

On 4 June, IFPMA delivered a statement on Priority I “Health Emergencies Prevention, Preparedness, and Response” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Statement 5 Jun 2023

G20 3rd Health Working Group Meeting: Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)

On 4 June, IFPMA delivered a statement on Priority II “Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Statement 5 Jun 2023

G20 side event on Global Vaccine Research Collaborative

On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Top